LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

Search

ResMed Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

244.25 -0.1

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

244.25

Max

245.16

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-31M

349M

Pardavimai

-12M

1.3B

P/E

Sektoriaus vid.

25.248

78.892

Pelnas, tenkantis vienai akcijai

2.55

Dividendų pajamingumas

0.89

Pelno marža

26.096

Darbuotojai

10,600

EBITDA

-29M

503M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+21.19% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.89%

2.38%

Kitas dividendų mokėjimo data

2026-03-19

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.8B

36B

Ankstesnė atidarymo kaina

244.35

Ankstesnė uždarymo kaina

244.25

Naujienos nuotaikos

By Acuity

12%

88%

11 / 374 reitingas Healthcare

ResMed Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-24 21:41; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

2025-12-24 14:57; UTC

Įsigijimai, susijungimai, perėmimai

Accenture to Acquire Cabel Industry from Fibonacci Group

2025-12-24 12:48; UTC

Pagrindinės rinkos jėgos
Įsigijimai, susijungimai, perėmimai

Repare Therapeutics Shares Rise on $30 Million Asset Deal With Gilead

2025-12-24 12:21; UTC

Pagrindinės rinkos jėgos

Nike Shares Tick Up After Apple CEO Tim Cook Buys $2.9 Million of Its Stock

2025-12-24 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

2025-12-24 21:26; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

2025-12-24 19:35; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-24 19:35; UTC

Rinkos pokalbiai

Treasury Yields Decline Ahead of Christmas -- Market Talk

2025-12-24 19:09; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Global Equities Roundup: Market Talk

2025-12-24 19:09; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

2025-12-24 19:06; UTC

Rinkos pokalbiai

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

2025-12-24 19:03; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Give Back Some Gains -- Market Talk

2025-12-24 17:20; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2025-12-24 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-24 17:08; UTC

Įsigijimai, susijungimai, perėmimai

This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

2025-12-24 16:53; UTC

Įsigijimai, susijungimai, perėmimai

Nike Climb Boosts Dow, S&P 500 -- WSJ

2025-12-24 16:31; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

ServiceNow Gets Top-Tier Asset and Talent With Armis Buy -- Market Talk

2025-12-24 16:28; UTC

Įsigijimai, susijungimai, perėmimai

Lam Research Is at All-Time Highs. Its CEO Just Sold $27 Million Worth of Stock. -- Barrons.com

2025-12-24 16:17; UTC

Rinkos pokalbiai

Dollar Stable as U.S. Layoffs Remain at Bay -- Market Talk

2025-12-24 15:33; UTC

Įsigijimai, susijungimai, perėmimai

Nike Shares Get a Lift After Apple's Tim Cook Doubles His Personal Stake -- WSJ

2025-12-24 15:30; UTC

Įsigijimai, susijungimai, perėmimai

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

2025-12-24 15:19; UTC

Įsigijimai, susijungimai, perėmimai

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

2025-12-24 14:49; UTC

Įsigijimai, susijungimai, perėmimai

Mexico's Ollamani Sells Stake in Azteca Stadium

2025-12-24 14:19; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Move Lower After Big Jump -- Market Talk

2025-12-24 14:08; UTC

Įsigijimai, susijungimai, perėmimai

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

2025-12-24 14:06; UTC

Rinkos pokalbiai

Oil Futures Edge Up on Geopolitical Risk Premium -- Market Talk

2025-12-24 13:24; UTC

Rinkos pokalbiai

Canada's Economy Needs More Help Amid Dismal GDP Report -- Market Talk

2025-12-24 12:59; UTC

Įsigijimai, susijungimai, perėmimai

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

2025-12-24 12:51; UTC

Įsigijimai, susijungimai, perėmimai

Disney Could Be the Real Winner from the Warner Takeover Battle. Here's Why. -- Barrons.com

2025-12-24 12:38; UTC

Įsigijimai, susijungimai, perėmimai

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

ResMed Inc Prognozė

Kainos tikslas

By TipRanks

21.19% į viršų

12 mėnesių prognozė

Vidutinis 296.44 USD  21.19%

Aukščiausias 345 USD

Žemiausias 260 USD

Remiantis 13 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines ResMed Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

13 ratings

7

Pirkti

6

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

11 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat